Prevalence of Lipodystrophy and Metabolic Abnormalities in HIV-infected African Children after 3 Years on First-line Antiretroviral Therapy

@inproceedings{BwakuraDangarembizi2015PrevalenceOL,
  title={Prevalence of Lipodystrophy and Metabolic Abnormalities in HIV-infected African Children after 3 Years on First-line Antiretroviral Therapy},
  author={Mutsawashe F Bwakura-Dangarembizi and Victor Musiime and Alexander J Szubert and Andrew J. Prendergast and Zvenyika A. R. Gomo and Margaret J Thomason and Cuthbert Musarurwa and Peter Mugyenyi and Patricia Nahirya and Adeodata Kekitiinwa and Diana M Gibb and A Sarah Walker and Kusum Jackison Nathoo},
  booktitle={The Pediatric infectious disease journal},
  year={2015}
}
BACKGROUND Most pediatric lipodystrophy data come from high-income/middle-income countries, but most HIV-infected children live in sub-Saharan Africa, where lipodystrophy studies have predominantly investigated stavudine-based regimens. METHODS Three years after antiretroviral therapy (ART) initiation, body circumferences and skinfold thicknesses were measured (n = 590), and fasted lipid profile assayed (n = 325), in children from 2 ARROW trial centres in Uganda/Zimbabwe. Analyses compared… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 36 references

High ratio of triglycerides to HDL - cholesterol predicts extensive coronary disease

  • PL daLuz, D Favarato, Faria-Neto
  • Clinics ( Sao Paulo )
  • 2013

Similar Papers

Loading similar papers…